eLife · 2020 · 26 citations · 68 references
Life SciencesGeneticsMolecular GeneticsMolecular NeuroscienceNeurodegenerationNeurogeneticsMolecular NeurogeneticsNeurodegeneration MechanismsNeurodegenerative Disease GeneticsNeurodegenerative DiseasesNeurodegenerative DisordersSpinocerebellar AtaxiasAggregationDrosophila Disease ModelsDrosophila ModelsPolyglutamine DiseasesPolyglutamine Expansion DisordersRegulation By E3 Ubiquitin LigasesSpinocerebellar Ataxia Type 3Ubiquitin-binding Domains
Spinocerebellar ataxia type 3 (SCA3) belongs to the family of polyglutamine neurodegenerations. Each disorder stems from the abnormal lengthening of a glutamine repeat in a different protein. Although caused by a similar mutation, polyglutamine disorders are distinct, implicating non-polyglutamine regions of disease proteins as regulators of pathogenesis. SCA3 is caused by polyglutamine expansion in ataxin-3. To determine the role of ataxin-3’s non-polyglutamine domains in disease, we utilized a new, allelic series of Drosophila melanogaster . We found that ataxin-3 pathogenicity is saliently controlled by polyglutamine-adjacent ubiquitin-interacting motifs (UIMs) that enhance aggregation and toxicity. UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner. Hsc70-4 also enhances pathogenicity of other polyglutamine proteins. Our studies provide a unique insight into the impact of ataxin-3 domains in SCA3, identify Hsc70-4 as a SCA3 enhancer, and indicate pleiotropic effects from HSP70 chaperones, which are generally thought to suppress polyglutamine degeneration.
68
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Yoshiya Kawaguchi, Toshihiro Okamoto, Masafumi Taniwaki et al. · Nature Genetics · 1994 · 1.8K citations
Ataxin-1 Nuclear Localization and Aggregation
Ivan A. Klement, Pamela J. Skinner, Michael D. Kaytor et al. · Cell · 1998 · 962 citations · Full text